Drug Patent Expirations in February 2012
Drug Patent Expirations in February 2012
*Drugs may be covered by multiple patents
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration |
|---|---|---|---|---|
| VISUDYNE | Qlt | verteporfin | 6,074,666 | Feb 5, 2012 |
| GANIRELIX ACETATE INJECTION | Organon Usa Inc | ganirelix acetate | 4,801,577 | Feb 5, 2012 |
| ALINIA | Romark | nitazoxanide | 5,387,598 | Feb 7, 2012 |
| AZILECT | Teva | rasagiline mesylate | 5,786,390 | Feb 7, 2012 |
| AZILECT | Teva | rasagiline mesylate | 5,387,612 | Feb 7, 2012 |
| AZILECT | Teva | rasagiline mesylate | 5,457,133 | Feb 7, 2012 |
| LOVENOX | Sanofi Aventis Us | enoxaparin sodium | RE38743 | Feb 14, 2012 |
| LOVENOX (PRESERVATIVE FREE) | Sanofi Aventis Us | enoxaparin sodium | RE38743 | Feb 14, 2012 |
| LOVENOX (PRESERVATIVE FREE) | Sanofi Aventis Us | enoxaparin sodium | 5,389,618 | Feb 14, 2012 |
| LOVENOX | Sanofi Aventis Us | enoxaparin sodium | 5,389,618 | Feb 14, 2012 |
| ACANYA | Dow Pharm Sci | benzoyl peroxide; clindamycin phosphate | 6,117,843 | Feb 18, 2012 |
| OPTISON | Ge Healthcare | albumin human | 5,558,094 | Feb 28, 2012 |
This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.
Courtesy of DrugPatentWatch.com
I wonder how 12 patents/mo. compares to previous years? I am assuming it is a relatively high number considering how 2012 has been reported to be a big year in patent expiration..